Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ARTHRITIS AND RHEUMATISM ASSOCIATES PC

NPI: 1447259866 · ROCKVILLE, MD 20850 · Non-Pharmacy Dispensing Site · NPI assigned 07/18/2005

$2.79M
Total Medicaid Paid
60,340
Total Claims
51,442
Beneficiaries
54
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialKJOLHEDE, JOSHUA (HR GENERALIST)
NPI Enumeration Date07/18/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,079 $257K
2019 9,918 $305K
2020 5,696 $289K
2021 7,287 $376K
2022 9,880 $460K
2023 8,884 $622K
2024 8,596 $478K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,333 5,030 $725K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3,369 2,936 $570K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,682 1,511 $512K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 9,267 8,540 $287K
96401 886 873 $168K
96415 722 606 $103K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,462 1,373 $88K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 826 764 $58K
86140 5,440 5,093 $56K
80053 Comprehensive metabolic panel 5,859 5,498 $36K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 1,243 1,187 $34K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,422 1,311 $24K
85652 5,282 4,943 $20K
36415 Collection of venous blood by venipuncture 5,175 4,861 $18K
20611 1,083 737 $16K
81001 172 165 $14K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 448 379 $9K
20610 207 164 $6K
86160 324 289 $6K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1,741 493 $5K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 959 276 $4K
J1030 Injection, methylprednisolone acetate, 40 mg 306 289 $3K
84550 92 91 $3K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,216 621 $2K
J3111 Injection, romosozumab-aqqg, 1 mg 109 109 $2K
73562 30 29 $2K
73130 41 38 $2K
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg 27 12 $1K
86225 161 151 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes 469 143 $1K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 907 275 $1K
J0897 Injection, denosumab, 1 mg 1,355 1,294 $1K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 13 12 $978.59
90653 26 26 $843.93
87081 67 63 $785.65
J1040 Injection, methylprednisolone acetate, 80 mg 129 118 $761.71
G0008 Administration of influenza virus vaccine 131 112 $651.34
J1010 Injection, methylprednisolone acetate, 1 mg 34 33 $532.31
J3262 Injection, tocilizumab, 1 mg 524 259 $420.12
89060 65 61 $343.45
86200 117 117 $342.90
89051 79 74 $319.19
99442 13 12 $290.78
99215 Prolong outpt/office vis 13 13 $201.84
86431 102 102 $167.70
84165 39 39 $20.16
86255 116 110 $0.00
97162 13 13 $0.00
97164 28 28 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 77 73 $0.00
J1745 Injection, infliximab, excludes biosimilar, 10 mg 85 42 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 29 29 $0.00
82570 12 12 $0.00
86038 13 13 $0.00